Join
Live feed
·
INSIDERFilingvia Quantisnow
Supernus Pharmaceuticals Inc. logo

Sr. VP of IP, CSO Bhatt Padmanabh P. converted options into 1,500 shares and sold $31,552 worth of shares (710 units at $44.44), increasing direct ownership by 6% to 14,508 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SUPN (Supernus Pharmaceuticals Inc.) and more on Quantisnow.